BioAtla, Inc. — Director's Dealing 2020

Dec 16, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2020-12-15

Reporting Person: Sievers Eric (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	76923	Direct

Footnotes

F1: Includes 76,923 restricted stock units ("RSUs"). 25% of the RSUs vest on October 29, 2021, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.